a zoto'l. shivangi parekh & co. chartered accountants lndependent auditor's review...
TRANSCRIPT
A zoto'healthcare ltd.
February 07,2020
To,The ManagerListing Department,The National Stock Exchange of lndia LimitedExchange Plaza,
Bandra Kurla Complex,Bandra (E), Mumbai - 400051
Dear Sir/ Madam,
Trading Symbol: ZOTA
Sub: Outcome of Board Meeting held on Friday, February OZ,2OZO
Ref': Regulation 30 & 33 of the sEBl (tisting obligations and Disclosure Requirements) Regulations,20L5
with reference to the captioned subject, we would like to inform you that the Board of Directors of ZotaHealth care Limited (the "company") in its Meeting held on Friday, February 07,2o2oat 03:00 p,M. atthe registered office of the company situated atzota House, 2/896, Hira Modi street, sagrampura, surat- 395002 have, inter a/io, discussed and approved the following business:
1'' considered and approved unaudited standalone and consolidated financial results for thequarter and nine months ended on December 31, 2oL9 along with Limited Review Reportsthereon' Financial Results and Limited Review Reports are enclosed herewith (Annexure - t).
Further, unaudited standalone and consolidated financial results for the period asaforementioned shall be available on the website of the stock Exchange where the shares of theCompany is listed i.e. at www.nseindia,com and on Lorprny,, website atwww.zota hea lthca re. com
The Board meeting concluded at 05:50:p.M.
This is for your information and record.
Thankin[ you,
Yours faithfully,
For Zota Health Care Limited !
l
1
Ashvin Variya(Company Secretary & CompliancePIace: Surat
6"'*$-; )l<.\ )o$t-*-,r'f
Encl: a/a
Registered offiee:Zoto House, 2/896, Hira Modi Street,Sogrompuro, Surot - 395 OO2 | Ph: +91 261 2331601Emoil: [email protected] : www.zotqhec lthco re.com
Plot no. .i69,
Surot Speciol Economic Zone,Nn Scchin Railway Stotion, Scchin,Surot - 394 23O (Guj; 1ry4;oPh: +91 261 2397122.,..'
*i,
,.i...'
CIN : L24231GJ2OOOPLCO3B352
1..
2.
3.
SHIVANGI PAREKH & CO.CHARTERED ACCOUNTANTS
lndependent Auditor's Review Report on Review of Standalone Unaudited Quarterlv Financial Results ofthe Companv Pursuant to the Resulations 33 of the SEBI (Listing Oblisations and Disclosure
Requirements) Resulations, 20L5, as ameneled
To
The Board of Directors ofZota Health Care Limited
We have reviewed the accompanying statement of unaudited financial results of Zota Health CareLimited (the "Company") for the quarter and nine months ended December 31, 2019 {the"Statement") attached herewith, being submitted by the Company pursuant to requirements ofRegulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20L5, as
amended (the "Regulation").
This Statement, which is the responsibility of the Company's Management and approved by theCompany's Board of Directors, has been prepared in accordance with the recognition andmeasurement principles laid down in the lndian Accounting Standard 34 "lnterim FinancialReporting" ("lnd AS 34"), prescribed under Section 133 of the Companies Act, 20L3 read withrelevant rules issued thereunder and other accounting principles generally accepted in lndia. Ourresponsibility is to express a conclusion on the Statement based on our review.
We conducted our review of the Statement in accordance with the Standard on ReviewEngagements (SRE) 24tO "Review of lnterim Financial lnformation Performed by the tndependentAuditor of the Entity', issued by the lnstitute of Chartered Accountants of lndia. This standardrequires that we plan and perform the review to obtain moderate assurance as to whether thefinancial statements are free of material misstatement. A review is limited primarily to inquiries ofcompany personnel and analytical procedures applied to financial data and thus provides lessassurance than an audit. We have not performed an audit and accordingly, we do not express anaudit opinion.
Attention is drawn to Note no.3 of the Statement which states that the Comparative figures ofquarter and nine months ended December 31., 2018 as reported in the accompanying Statementhave been restated by the management of the Company and prepared by exercising necessary duediligence to ensure that the financial results reflect true and fair view of Company's affairs but havenot been subjected to review. .i
Based on our review conducted as above, nothing has come to our attention that causes us tobelieve that the accompanying statement of unaudited financial results prepared in accordance withapplicable accounting standards and other recognized accounting practices and policies has notdisclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (ListingObligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is tobe disclosed, or that it contains any material misstatement.
4.
DatetOT(A2/2O2O
Place: Surat
For Shivangi Parekh & Co.
Chartered AccountantslCAt FRN: 1314,t9,W
.o.rnd#n."Proprietor
M. No.118935UDIN:r(oJt <13 6 AAAAAISL6T
302, SA! BHAVAN, NR. NEW SAIBABA TEMPLE, Opp. SMC MULTTLEVET PARKING, SHAHPORE,
sURAT-395002.
ooo
L.
SHIVANGI PAREKH & CO.CHARTERED ACCOUNTANTS
lndependent Auditor's Review Report on Review of Consolidated Unaudited Quarterlv Financial Results
of the Companv Pursuant to the Resulations 33 of the SEBI (Listine Obligations and Disclosure
Requirements) Regulations, 2015, as amended
To
The Board of Directors ofzota Health Care Limited
We have reviewed the accompanying Statement of Consolidated Unaudited Financial Results of Zota
Health Care Limited ("the Parent") and its subsidiaries (the Parent and its subsidiaries together
referred to as "the Group"), and its share of the net profit/(loss) after tax and total comprehensive
income / loss for the quarter and nine months ended December 3t,2}1rg ("the Statement"), being
submitted by the Parent pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, as amended. (the "Regulation").
This Statement, which is the responsibility of the Parent's Management and approved by the Parent's
Board of Directors, has been prepared in accordance with the recognition and measurement
principles laid down in lndian Accounting Standard 34 "lnterim Financial Reporting" ("lnd AS 34"),
prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally
accepted in lndia. Our responsibility is to express a conclusion on the Statement based on our review.
We conducted our review of the Statement in accordance with the Standard on Review Engagements
(SRE) 2410 "Review of lnterim Financiol lnformotion Performed by the lndependent Auditor of the
Entity', issued by the lnstitute of Chartered Accountants of lndia. A review of interim financial
information consists of making inquiries, primarily of persons responsible for financial and accounting
matters, and applying analytical and other review procedures. A review is substantially less in scope
than an audit conducted in accordance with Standards on Auditing and consequently does not enable
us to obtain assurance that we" would become aware of all significant matters that might be
identified in an audit. Accordingly, we do not express an audit opinion.
We also performed procedures in accordance with the circular issued by the SEBI under Regulation
33 (8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20L5, as amended,
to the extent applicable.
Attention. is drawn to Note no. 3 of the Statement which states that the Comparative figures ofquarter and nine months ended December 31, 2018 as reported in the accompanying Statementhave been restated by the management of the Company and prepared by exercising necessary duediligence to ensure that the financial results reflect true and fair view of Company's affairs but have
not been subjected to review.
The Statement includes the results of the following entities:":
a. Zota Health Care Liniited (Parent)
b. Zota Healthcare Lanka (Pvt) Ltd (Subsidiary)
2.
3.
4.
302, SAI BHAVAN, NR. NEW SAIBABA TEMPLE, OPP. SMC MULTILEVEL PARKING, SHAHPORE,
sURAT-395002.
SHIVANGI PAREKH & CO.
CHARTERED ACCOUNTANTS
5. Based on our review conducted and procedures performed as stated in paragraph 3, nothing has
come to our attention that causes us to believe that the accompanying Statement, prepared in
accordance with the recognition and measurement principles laid down in the aforesaid lndian
Accounting Standard and other accounting principles generally accepted in lndia, has not disclosed
the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations,2Ol5, as amended, includingthe manner in which it is to be
disclosed, or that it contains any material misstatement.
6. We did not review the interim financial statements of the subsidiary included in the consolidated
unaudited financial results that reflect total revenues of Rs. Nil, total net loss after tax of Rs. 3148 and
Rs. 8528 and total comprehensive loss of Rs.3148 and Rs. 8528, for the quarter and nine months
ended 31,.12.2019, respectively, as considered in the consolidated unaudited financial results. These
interim financial statements have been reviewed by other auditors whose reports have been
furnished to us by the Management and our conclusion on the Statement, in so far as it relates to the
amounts and disclosures included in respect of this subsidiary is based solely on the report of the
other auditors and the procedures performed by us as stated in paragraph 3 above.
Our conclusion on the Statement is not modified in respect of the above matters.
For Shivangi Parekh & Co.
Chartered AccountantsICAIFRN: 131449W
Date:O7lo2l2o20Place: Surat
' \xJ#yCA. Shi'vangiMehta
ProprietorM. No.118936
uDrN: d0tL{13iAAfrAAf il+9 6
302, SAI BHAVAN, NR. NEW SAIBABA TEMPLE, OPP. SMC MUTTILEVEL PARKING, SHAHPORE,
sURAT-395002.
A zoto'healthcare ltd.
ZOTA HEAI.TH GRE TIMITED
Standalone f inahclal Stat€ments
Statement ot Unaudited ainancial Results for the euaner and Nine Month, ended 31.t Oecember, 2019
Pani(ulaE
I Quart$Ended : Nin. Monthr3Llt2ltoLa(unaudited)
3Lh2l2otg(Un.udhed)
l.
li.
1il.
vl[.
tx.
x.
xl.
x[.
xil.xtv.
levenue from Operation!f,thet lncomes
2s06.38
30.74
2528.7:
37.41
2!76.4717.38
1 203.3L
98.04
6503.0i117.6:
8562.94
754.47
2517.r 24 2193.85 73 6620.6[ a7L7
€xpenses:
Cost of Materials Consumed:
Purchases of Sto.k-in-Trad€
Changer in lnventori€s of Finished 6oods. Work-tn-progress andStock-in-Trade
Employ€e Benefit Exp€nses
Finance Costs
0epreciation / Amonisallon and Depletion Expense
Other Expenses
430.0;
1069_1:
287.1!
263.0(
48.0t
383.6i
179.70
1451.28
163.86
258.99
1.O2
32.05
332_94
297.A4
1366,3{
-131.L1
228.39
1.4537.L4
388.34
972.2i3s67.9:
540.4t765.5(
4.6i110.1(
1.056.4i
783.31
4313.27
-733.98
631.14
2.16113.07
898.30
1151.O0
5276.35
-725.97
889.19
3.68139.42
1197.81
otal Expenses 2443.4 2419.8/ 2188.39 70L7.4t 6007.2! 793L.49
Profit before Erceptional items and tax irom continuing operations(r1l,lvl
Exceptional ltems
Proflt/(loss) before tax
Tax Expense:
(1) Curent tax(1.1) l.T. & DDTax Provision Created Shon/excess(2) oeferred Tax
Profit/ (Lossi for the perbd from ConrinuinsOperations (Vll-VlU)
Profit/(loss) before tax from discontinued operations
Tax Expen5e of discontinued Operations
Profit/ (Loss) from Dis.ofl tinued Operations (af(er Tax)(x- xr)
Profit/ (Loss) Ior the Year
Other Comprehensiv€ lncomeA (i) ltems that will not be reclassified to Statement of
profrl and loss
{iii lncom€ Tar relating to items thar will nor bereclassified to Statement o, profit and toss
B ii) ltems that will be.eclassified ro Statemeni of profitand lort
(ii) locone Tax relating to items thal wrll be reciassifjed
to profit and loss
Ither comprehensive income for the year, net o, taxfotal comprehensive income for the year {Xlll + XIV)
,aid-up [quity Share Capital
:arnings pe. equity share of face value of a 10 each1) Basic (in l)2) Diluted {in l)
53.71
53.71
1s.80
0.14
38.04
146.40
146.40
36.8 1
-0.49
109.11
s,45
5.45
'18.68
0.13
3.77
27.78
283.8S
73.69
0.26
-6.62
203.33
613.37
613.37
119_29
2.34
4.47
440.21
785.92
785.92
23?_43
2.34
4.03
555. 19
3t"04
0.18
-0.05
o.a,
109.1
4.59
-1.15
27,,78 203.3:
16.2i
-4.0s
440.21 s55.1!
2.5(
38.18
2456.03
0.1s
112.54
2456.03
0.44
044
21,7A
1754.34
0.11
0.11
215.5{
2456.O:
0.83
o.a3
440.21
1154.34
1.79
1.79
548.54
L154.34
2.26
For ahd on behaltofthe Board Shivangi Parekh & Co.
Chadered Accountantr
- r ...1"\ t'rA' \('
CA. Shivangi MehtaProprietor
M. No. 11a935
tirm No,131449W
tQfl.,.,h^(Whole Time Director)
i*::*,Y;:"
6,'wCompanySecretary
Date:07-02-2020Place: surat
(Din ,07625219)
I
I
l
1
Reghtered office:Zoto House, 2/896, lliro Modi StreetSogrompuro, Surot - 395 OO2 | Ph: +91 261 23316c-1Emoil: [email protected] : wvwvzotqheo lthcore.com
- -- ..-i.,
I
l!Plont: i iPlot no. 169, Surot Speciol ficonomic Zon,e,Nr. Sochin Rollwoy StatioD/'Sochin. ISurot - 394 23O (cuj.) l2dia i ...Ph: +91 261 2397122 ..,' t.,'
&t*r-*<i l-St.---'i9
CIN : L24231GJ2OOOPLCO3B352
Lli'l
$F3Llt2l2oL9
(Unaudlt.d)
3UrU2019
(Un.udlted) (Audited)
3-J,nr rnn'\9
A zoto'healthcare ltd.
ZOTA HEAITH CAEE I,IMIIED
Consolidated noilclal Statement5
Statement gf Uaaudlted Financial Resul$ fo, the quarter and Nire Months ended 3lst December, 2019
ShivanB, Pareth & Cc,
Charlered Acaountants
^,.r\t*\ ''4t:'CA. ShivanSi Mehta
PropdetorM, No.118936
Firm No. 131449W
Plant:Plot no 169, Surct Speciol Economic Zone,Nr. Sochin Roilwoy StatioDi'Sochin. ISurot - 394 23O (cuj.) l2l;qPh: +9'l 261 2397122.....' ..,,..
')-
quarter Ended
(Unaudited) |
(unaudhed)
| 3L172120L8 ltl| (unaudited)
]
I lReferNote-3&4) I
t.
il.
1il.
vl[.
lx.
x.
xt.
xil.
xilt.xlv.
Revenue from OperationsOther lncomes
2506.3830.74
252A.75
17.492176.4i
17.3t7203.37
98.046503.02
777.638562.94
!54.47
Total Revenue 2517,1 2566. 7301.3! 6620.66 4717
ExpenseslCost of Materials Consumed:Purchases of Stock-in-Trade
Changes in lnventories of Finished Goods. work-in-Progress and Stock.in-TradeEmployee Benefit Expenses
Finance Costs
Depreciation / Amortisation and Depletion Expen5e
Other Expenses
430.07
1069.13
287.15
263.002.31
48.08383.71
119.701451.28
163.86258.99
1.02
32.05332.98
297.841366.34
- 131.11228.39
37.14388.70
972.2:3567.9!
540.4f765.5(
4.6t
110.1[
1056.5:
783.314173.27
.733.98
631.14
2.76
113.07898.66
1151.0(5276.3!
-725.9)
889.1!
139.4i
1198.1t
fotal El 2419.88 2188.7! 7017.S! 5007 7931.8r
Proflt before Exceptional items and tax from continuing operations(ilr-rv)
Exceptional ltems
Profit/{loss) before taxTax Expense:
{1) Current tax
{1.1) l.T. & DD Tax Provision Created Short/ excess(2) Deferred
Profit/ (Loss) lor the period from ContinuinSOperations {Vll-Vlll)
Profit/(loss) before tax from discontin!ed operatlons
Tax Expense of discontinued Operations
Profit/ (Loss) from Discontinued Operations (after Tax)(x- xl)
Profit/ (!oss) for the YearOther Comprehensive lncomeA {i) ltems that will oot be reclassified to Statcment ot
profit and loss(ii) lncome Tax relating to items that will not be
reclassified to Statement of profit and loss
B (i) ltems that will be reclassified to Statement of profitand loss
(ii) lncome Tax relating to items that will be .eclassified
to profit and loss
Other comprehensive income for the year, net of taxTotal comprehenrlve income for the year (Xlll + XIV)
Profit attributable to:Owoers ot the parentNon.controlljng interest
Other comprehensive income attributable to:Owners of the parent
Non-controlling interestPaid-up Equity Share CapitalEarnings per equity share of face value of a 10 each(1) Basic (in <)(2) Diluted (in o
53.68
53.68
15.800.000.14
38.01
146.36
36.810.00
.0.49
109.07
5.1(
5.1(
18.6t0.1:3.7i
27.42
283.8(
283.8(
73.65
0.2f-6.6i
203.24
613.01
613.01
r19.292.34
8.47
439.85
785.5i
785.5;
232.4i
4.04
554.82
38.01
0.1t
-0.0!
0.01
o-1
r09,o,
4.5!
-0.0s
I
27.42
0.00
0.00
-0.11
.o 1i
203.24
!6.27
-4.09
-0.08
439.85
0.00
0.00
-0.11
-0.11
554.84
-9.22
2.56
0.01
0.00
38.1(
38.01
0.1I
2456.03
0.150.15
I t2,41
109.0,
3.34
2455.0:
o.44
zl,al
27-.42
-0.11
1"154.34
0.11
215.34
203.24
12-.rO
2456.03
0.830.83
439.75
439.8!
-0.1!
7754.34
t.7917q
548.20
554.84
-6.64
17 54.14
2.26
;;;ffi"""""ifti(Whole Time Director) iMaftgrfrt Director)Himanshu M. Zota Moxerh K. Zota(Din :010977221 (Din | 076252191
Ashvln Va.iya
Datet o7 l02l2O2OPlace : Surat
Registered Qffice:Zoto Housq 2/a96, Hiro Modi Street,Sqgrampuro, Surqt - 395 OO2 | Ph: +91 261 23316C-1Emoil: info@zotohealthco re.comWeb : wwwzotcheo lthcore.com
CIN : L24231GJ2OOOPLCO3B352
__.__-_,1-- -, -.--_-__
@
A zoto'healthcare ltd.
Notes:
Registered Offce:Zotq Housq 2/896, Hiro Modi Street,Sogrompura, Surot - 395 OO2 I Ph: +91 261 23316C-1Emoil: [email protected] : wwwzotohec lthcore.com
The above financial results for the quarter and nine months ended December 31, 2019 have
been reviewed and recommended by the Audit Committee and subsequently approved by theBoard of Directors at their meeting held on February 07,2020.The Statutory Auditors have carried out Limited Review of the financial results for the quarterand nine months ended December 31,,2019.The Company has migrated to the main Board of National Stock Exchange w.e.f. August t9,2Ot9accordingly the Company has not prepared financial results for the quarter and nine monthsended December 31, 2018. However, Comparative figures of quarter and nine months ended
December 3L, 20L8 have been restated by the management of the Company and prepared by
exercising necessary due diligence to ensure that the financial results reflect true and fair viewof Company's affairs. Financial results for the quarter and nine months ended December 3L,
2018 have not been subjected to limited review report of auditor.Till 31't March, 2019, the company has obtained Actuarial Valuation Report of Gratuity on halfyearly basis; hence the respective figures of actuarial gain or loss have not been considered forthe quarter and nine months ended December 31, 2018. However, this does not have any
material impact on the results of the said period.
5. The Company has evaluated its Operating segment in accordance with IND AS 108 and has
concluded that it is engaged in a single operating segment.
The consolidated results include the result of Company's wholly owned subsidiary company Zota
Healthcare Lanka (PW) Ltd.
Tax expanses for the quarter and nine months ended December 31,20t9 have been calculatedas per Taxation Laws (Amendment) Ordinance 2019, the income-tax is calculated at the reduced
rate from the current financial year,
On July 29, 20tg Company has issued 70t6975 bonus shares in the ratio of 4:10 [i.e. a (Four)
fully paid up equity shares for every 10 (Ten) equity shares held.l Earning Per Share (EPS) for all
the reporting period before the said bonus issue have been restated as per IND AS 33.
Figures pertaining to the previous period have been regrouped/rearranged, reclassified and
restated wherever considered necessary, to make them comparable with those of current"period.
i
Plont: I i \\\.\_ I
Plot no. 169 Surot Speciol Economic Zong,Nr. Scchin Roilwoy Stotiory; Sochin , .---'Surot- 394230 (Guj.) tgdq i -.'Ph: +91 2G12397i22/..' l.'
,, i'u""-' ,'/' \" \
,/t' t-...__._-
,/,
2.
3.
4.
6.
7.
8.
9.
#*s<{ i5fr*lt'-*-r"')
clN 1_24231GJ2000PLCO38352
6tre